Cationic peptide carriers enable long-term delivery of insulin-like growth factor-1 to suppress osteoarthritis-induced matrix degradation

被引：0
|
作者：
Armin Vedadghavami
Bill Hakim
Tengfei He
Ambika G. Bajpayee
机构：
[1] Northeastern University,Department of Bioengineering
[2] Northeastern University,Departments of Mechanical Engineering
来源：
Arthritis Research & Therapy | / 24卷
关键词：
Insulin-like growth factor-1; Charge-based drug delivery; Intra-cartilage depot; Cationic peptide carriers; Electrostatic interactions; Cartilage therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor
    Stawowy, P
    Kallisch, H
    Kilimnik, A
    Margeta, C
    Seidah, NG
    Chrétien, M
    Fleck, E
    Graf, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (03) : 531 - 538
  • [22] Effects of chronic growth hormone/insulin-like growth factor-1 deficiency on osteoarthritis in rat knee joints
    Ekenstedt, KJ
    Sonntag, WE
    Loeser, RF
    Lindgren, BR
    Carlson, CS
    OSTEOARTHRITIS AND CARTILAGE, 2004, 12 : S7 - S8
  • [23] Potent Long-Term Cardioprotective Effects of Single Low-Dose Insulin-Like Growth Factor-1 Treatment Postmyocardial Infarction
    O'Sullivan, John F.
    Leblond, Anne-Laure
    Kelly, Geraldine
    Kumar, Arun H. S.
    Metharom, Pat
    Bueneker, Chirlei K.
    Alizadeh-Vikali, Niki
    Hristova, Ivalina
    Hynes, Brian G.
    O'Connor, Rosemary
    Caplice, Noel M.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (04) : 327 - U61
  • [24] EVIDENCE THAT ENDOGENOUS INSULIN-LIKE GROWTH FACTOR-1 ATTENUATES ENDOTOXIN INDUCED CACHEXIA
    May, P.
    Plymate, S.
    Wisse, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 214 - 214
  • [25] MENDELIAN RANDOMIZATION IDENTIFIES A CAUSAL ROLE FOR SERUM INSULIN-LIKE GROWTH FACTOR-1 IN HIP OSTEOARTHRITIS
    Hartley, A. E.
    Sanderson, E.
    Paternoster, L.
    Granell, R.
    Tobias, J. H.
    Gregson, C. L.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S72 - S72
  • [26] Downregulation of Insulin-Like Growth Factor-1 Receptor Mediates Chondrocyte Death and Matrix Degradation in Kashin-Beck Disease
    Zhang, Meng
    Wang, Wenjun
    Wang, Hui
    Liu, Yinan
    Li, Zhengzheng
    Yi, Chengfen
    Shi, Yawen
    Ma, Tianyou
    Chen, Jinghong
    CARTILAGE, 2021, 13 (1_SUPPL) : 809S - 817S
  • [27] Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis
    Saeki, Chisato
    Kanai, Tomoya
    Ueda, Kaoru
    Nakano, Masanori
    Oikawa, Tsunekazu
    Torisu, Yuichi
    Saruta, Masayuki
    Tsubota, Akihito
    FRONTIERS IN MEDICINE, 2023, 10
  • [28] GROWTH HORMONE RELEASING PEPTIDE TREATMENT IN MEN INCREASES SERUM INSULIN-LIKE GROWTH FACTOR-1 LEVELS
    Sigalos, John T.
    Allison, Andrew
    Pastuszak, Alexander
    Ohlander, Samuel J.
    Herati, Amin
    Lindgren, Mark C.
    Lipshultz, Larry I.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1010 - E1010
  • [29] Insulin-Like Growth Factor-1 Levels in Term Newborns with Hypoxic-Ischemic Encephalopathy
    Umran, Raid M. R.
    Al-Tahir, Mahir
    Jagdish, Desai
    Chouthai, Nitin
    AMERICAN JOURNAL OF PERINATOLOGY, 2016, 33 (07) : 640 - 645
  • [30] Stimulation of stem cell factor (SCF) expression by insulin or insulin-like growth factor-1 (IGF-1) is required for the long-term maintenance of interstitial cells of Cajal (ICC)
    Horvath, VJ
    Vittal, H
    Redelman, D
    Almeida-Porada, G
    Ordog, T
    GASTROENTEROLOGY, 2004, 126 (04) : A102 - A102
12345